esmolol has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Affatato, R; Babini, G; Belloli, A; Boccardo, A; Cucino, A; De Giorgio, D; Fumagalli, F; Latini, R; Magliocca, A; Minoli, L; Nespoli, F; Novelli, D; Olivari, D; Pravettoni, D; Ristagno, G; Romanelli, P; Ruggeri, L; Scanziani, E; Staszewsky, L; Zani, D | 1 |
| Goyagi, T; Horiguchi, T; Nishikawa, T; Tobe, Y | 1 |
2 other study(ies) available for esmolol and Nerve Degeneration
| Article | Year |
|---|---|
Esmolol during cardiopulmonary resuscitation reduces neurological injury in a porcine model of cardiac arrest.
Topics: Animals; Blood Gas Analysis; Brain; Cardiopulmonary Resuscitation; Disease Models, Animal; Heart Arrest; Hemodynamics; Male; Nerve Degeneration; Neurons; Perfusion; Phosphopyruvate Hydratase; Pressure; Propanolamines; Swine | 2021 |
Post-treatment with selective β1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Animals; Brain Infarction; Brain Ischemia; Disease Models, Animal; Male; Morpholines; Nerve Degeneration; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Treatment Outcome; Urea | 2010 |